Recently
Drug Catalog for COVID-19 Infected Persons (First Edition) Released
Diclofenac Sodium Enteric-coated Sustained Release Capsules
Among them
To meet the increasing market demand in the near future
Located in Lujia Town
Dequan Pharmaceutical (Jiangsu) Co., Ltd
There is a busy scene in the production and packaging workshops
Try your best to adjust the production line and increase production capacity
Full horsepower productionDiclofenac sodium enteric-coated capsules
Diclofenac sodium enteric-coated capsules
And Diclofenac Sodium Enteric-coated Sustained Release Capsules in the catalog
The main ingredients are the same
It is a non-steroidal anti-inflammatory drug
It can relieve pain
Dequan Pharmaceutical (Jiangsu) Co., Ltd
Mainly produces diclofenac sodium enteric-coated capsules
Aspirin delayed-release capsules
Doxycycline hydrochloride enteric-coated capsules and other drugs
At present
Production of relevant drugs of the company
It has doubled over the same period last year
▲On December 16, the production picture of the enterprise was broadcast on the News Network
Recently, we have rearranged the production plan according to the needs of the market, and made every effort to ensure the normal supply of relevant drugs.
Xiaokun also learned that Dequan Pharmaceutical (Jiangsu) Co., Ltd. was renamed from "Yongxin Pharmaceutical Industry (Kunshan) Co., Ltd." in September 2022. It passed the GMP certification of the State Food and Drug Administration for the first time in May 1999 and the FDA certification of the United States for the first time in 2009. At present, the main product dosage forms include tablets, hard capsules, ointments, small volume injections, etc.
